Dark

Check out our Dark Pool Levels

DMTTF
SMALL PHARMA INC
stock OTC

Inactive

Oct 20, 2023

0.1117USD-9.686%(-0.0120)108,702

Pre-market

0.00USD-100.000%(-0.12)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 31, 2022

05:05PM EST Small Pharma Reports Fiscal Third Quarter 2021 Highlights GlobeNewswire Inc

Jan 4, 2022

07:50AM EST Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the Company or Small Pharma), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce its attendance at the 11th Annual LifeSci Partners Annual Corporate Access Event, and the H.C. Wainwright Bioconnect Conference, from January 5-7, 2022, and January 10-13, 2022, respectively. GlobeNewswire Inc

Dec 1, 2021

08:49AM EST Small Pharma to Participate in the H.C. Wainwright 2nd Annual GlobeNewswire Inc

Nov 18, 2021

02:04PM EST Small Pharma Strengthens Board With Appointment of Paul Maier as GlobeNewswire Inc

Nov 15, 2021

07:50AM EST Discussions With FDA Provide Guidance for Phase IIb Clinical Trial GlobeNewswire Inc

Nov 12, 2021

07:50AM EST Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the Company or Small Pharma), a neuropharmaceutical company focused on psychedelic-assisted therapies, is pleased to announce its attendance at the LSX Inv$tival ShowcaseTM conference and the Jefferies London Healthcare Conference during the month of November. GlobeNewswire Inc

Nov 8, 2021

09:06AM EST Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 Benzinga

08:54AM EST HC Wainwright & Co. Initiates Coverage On Small Pharma with Buy Rating, Announces Price Target of $2.5 Benzinga

Nov 1, 2021

05:28PM EDT Company advances ongoing clinical trials with Phase I completed and dosing initiated in Phase IIa trial for lead product candidate, SPL026, a DMT-assisted therapy for the treatment of Major Depressive Disorder GlobeNewswire Inc

Oct 27, 2021

09:25AM EDT Small Pharma Receives European Patent Of Ketamine-Based Compounds For Treatment of Depressive Disorders Benzinga

Oct 26, 2021

01:49PM EDT Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent Benzinga

Oct 25, 2021

07:50AM EDT European Patent Grant Strengthens Small Pharmas GlobeNewswire Inc

Oct 21, 2021

12:11PM EDT Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race Benzinga

07:50AM EDT Small Pharma Granted Fast-Track Designation From U.K. Regulator GlobeNewswire Inc

Oct 20, 2021

07:50AM EDT Small Pharma Announces Upgrade to the OTCQB and DTC GlobeNewswire Inc

Oct 18, 2021

01:37PM EDT Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation Benzinga

08:36AM EDT KCSA Psychedelics Virtual Investor Conference Presentations Available for PR Newswire

Oct 13, 2021

04:25PM EDT There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are Benzinga

Oct 11, 2021

08:20AM EDT KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th PR Newswire

Aug 9, 2021

07:01AM EDT Small Pharma To Present At Canaccord Genuity's Annual Growth Conference PR Newswire

Share